SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Official Melania Meme (MELANIA) is a cryptocurrency and operates on the Solana platform. Official Melania Meme has a current supply of 999,995,392.634966 with 999,995,392.634962 in circulation. The last known price of Official Melania Meme is 0.04540986 USD and is down -12.94 over the last 24 hours. It is currently trading on 310 active market(s) with $4,518,778.32 traded over the last 24 hours. More information can be found at https://melaniameme.com/.

Melania Trump

MELANIA is drawing attention over its steep decline and its status as a Trump-family meme coin, with many traders calling it a speculative cash grab and questioning its utility. A smaller group is discussing buying the dip or expecting a rebound, but the conversation is predominantly bearish and focused on losses and scam concerns.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor is drawing attention ahead of the FDAs November 22 decision on deramiocel for Duchenne muscular dystrophy, with discussion focused on whether the agency will accept the companys evidence for an upper-limb indication despite concerns about the trials statistical analysis. Traders are split between expecting approval and a potential short squeeze versus fearing a rejection or delay, making the upcoming decision a high-stakes binary catalyst.

Avalanche (AVAX) is a cryptocurrency launched in 2020. Avalanche has a current supply of 471,438,169.1160568 with 446,436,169.1160568 in circulation. The last known price of Avalanche is 6.99518175 USD and is down -15.00 over the last 24 hours. It is currently trading on 1135 active market(s) with $402,139,637.32 traded over the last 24 hours. More information can be found at https://avax.network/.

Avalanche

AVAX is drawing attention amid a sharp selloff, with traders frequently saying it is following Bitcoin lower while falling harder than many other altcoins. Some point to institutional tokenization developments, including the NYSE-related news, but debate whether those headlines create meaningful value for the token as price gains have repeatedly faded.

iShares Trust - iShares Biotechnology ETF

iShares Biotechnology ETF

Biotech-sector price action is the main focus, with traders watching IBB consolidate and comparing its relative steadiness with more volatile small-cap biotech. Views are mixed between patient optimism about sector strength and caution after recent pullbacks; no single company catalyst dominates.

Shiba Inu (SHIB) is a cryptocurrency launched in 2020and operates on the Ethereum platform. Shiba Inu has a current supply of 589,495,699,860,951.91490568 with 589,238,106,731,035.4551592 in circulation. The last known price of Shiba Inu is 0.00000379 USD and is down -10.85 over the last 24 hours. It is currently trading on 1128 active market(s) with $78,538,817.41 traded over the last 24 hours. More information can be found at https://shibatoken.com/.

Shiba Inu

SHIBs weak, choppy price action is driving discussion, with traders citing bearish technical structure and worrying about further losses or another zero being added. Others are buying dips and hoping for a rebound, while some argue that renewed burns or greater utility would be needed to revive momentum.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is drawing attention around the FDA decision on ivonescimab for EGFR-mutated lung cancer, with traders watching for an approval, a complete response letter, or a delay. The debate centers on strong progression-free-survival results and improving overall-survival data versus the FDAs stated need for statistically significant overall-survival evidence; the share-price decline has heightened uncertainty rather than resolved it.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

Golds sharp pullback is being tied to hotter inflation data and increased expectations for Fed rate hikes, which have lifted Treasury yields and the dollar. Traders are divided between expecting further losses and treating the selloff as a buying opportunity, with some long-term holders still viewing gold as a hedge.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,752,062,860.16806072. The last known price of Dogecoin is 0.05689686 USD and is down -11.89 over the last 24 hours. It is currently trading on 1545 active market(s) with $1,128,721,930.78 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoin is drawing attention amid a sharp crypto-market selloff, with traders pointing to its slide toward multi-year lows and broader weakness in Bitcoin and other tokens. The community is split between bearish calls for further losses and bulls treating the decline as capitulation and a buying opportunity.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Bitcoins sharp, volatile swings and recent weakness dominate discussion, with traders pointing to leveraged liquidations, spot-ETF outflows and broader risk-off pressure as possible contributors. The community is split between dip buyers expecting a rebound and bearish traders warning of further downside; no single cause is consistently established.

Bittensor (TAO) is a cryptocurrency launched in 2021and operates on the Bittensor platform. Bittensor has a current supply of 21,000,000 with 11,727,911.30015715 in circulation. The last known price of Bittensor is 182.74993229 USD and is down -15.42 over the last 24 hours. It is currently trading on 339 active market(s) with $220,769,283.80 traded over the last 24 hours. More information can be found at https://bittensor.com.

Bittensor

TAO is drawing attention amid a sharp pullback, with traders divided between buying the dip and waiting for further downside as broader crypto selling pressure weighs on sentiment. Long-term bulls point to Bittensors decentralized-AI and subnet potential, while cautious voices say adoption and value capture remain unproven.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

About CHBT